The Company had 908,441,782 common shares outstanding and, following the
Consolidation, will have approximately 181,688,356 common shares
outstanding. No fractional common shares of IDC will be issued. If
as a result of the Consolidation a holder would otherwise be entitled
to a fraction of a common share, the number of shares of IDC the holder
will receive will be rounded up if the fractional share is equal to or
greater than 0.5 and rounded down if the fraction is less than 0.5.
Each registered holder will have his holdings aggregated and will be
entitled to receive only one whole common share for any fractional
interest resulting from the Consolidation of his holdings, as
determined on an aggregated basis.
A Letter of Transmittal will be sent to shareholders advising them that
the Consolidation has taken place and instructing them to surrender
certificates representing pre-Consolidation common shares of the
Company in exchange for certificates representing post-Consolidation
common shares of IDC. Until surrendered, each certificate will be
deemed for all purposes to represent the number of common shares to
which the holder thereof is entitled as a result of the Consolidation.
The Company has over 3,000 installations in 50 countries of its
proprietary, award winning direct capture DR technology, which replaces
conventional film-based diagnostic imaging and provides a
cost-effective solution for medical facilities of all sizes to provide
high quality diagnostic X-ray images and improve the level of
healthcare for their patients.
Throughout its history, IDC has been recognized by multiple industry
organizations and research analysts such as:
The Company has its corporate office in
Visit the IDC web site: www.imagingdynamics.com
Statements in this release which describe IDC's intentions, expectations or predictions, or which relate to matters that are not historical facts are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties which may cause the actual results, performances or achievements of IDC to be materially different from any future results, performances or achievements expressed in or implied by such forward-looking statements. IDC may update or revise any forward-looking statements, whether as a result of new information, future events or changing market and business conditions. Known and unknown risks and uncertainties include: IDC's ability to manufacture its products with a sufficient level of quality and in volumes which satisfy market demand; the ability of IDC to establish direct and indirect sales channels; the ability of IDC to establish industry partnerships; IDC's ability to attract and retain key personnel; the strength and breadth of IDC's patents; and other factors relating to general economic conditions, specific industry conditions and IDC's particular situation.